Ustekinumab: A New Option for IBD Patients in Mumbai
Ustekinumab is a newer biologic medication approved for the treatment of Crohn’s disease and ulcerative colitis. It targets interleukin pathways involved in the immune response, helping reduce intestinal inflammation and promote healing. In Mumbai, ustekinumab is gaining popularity due to its effectiveness in patients who have not responded well to other treatments like infliximab or adalimumab. The treatment is administered via injection and requires ongoing medical supervision to monitor response and side effects. For those living with Inflammatory Bowel Disease in Mumbai, consulting with a gastroenterology specialist such as Dr. Harshad Joshi can provide access to advanced treatment options, including ustekinumab, to manage symptoms and improve daily living.
